The Latest Breaking News on Pharma

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.

Looking for some truly wowing profit growth from S&P 500 companies. A few are likely to knock your socks off.

Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.

Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.

This leading medical device maker is showing constructive action in a flat base and setting up for its next move.

Danish drug company gave money for Google ads to promote weight loss services and received data on web traffic and prescriptions

Tarsus Pharmaceuticals drew its inspiration from animal-health drugs. Now, the biotech stock is on a triple-digit run.

The specialty pharma sector is leading the charge in developing life-changing solutions for rare and chronic conditions. Amid this backdrop, investors might consider adding three fundamentally solid specialty pharma stocks, namely, Ipsen S.A. (IPSEY), ACADIA Pharmaceuticals (ACAD), and Neurocrine Biosciences (NBIX) in their portfolios. Read on….

Missed out on giant S&P 500 winners this year like Nvidia and Eli Lilly? Don't worry: Analysts think you'll get another shot in 2025.

The judge presiding over pre-trial hearings for Luigi Mangione has come under scrutiny for her financial and familial ties to the healthcare industry.

If GILD stays below 100, the investor can continue selling call options until the shares get called away.